Cue Biopharma, Inc.

CUE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017
Assets
Cash & Equivalents —
Accounts Receivable —
Inventory —
Total Current Assets $65.1M
Property, Plant & Equipment $1.7M
Goodwill —
Intangible Assets (Excl. Goodwill) —
Total Assets $67.0M
Liabilities
Accounts Payable $1.7M
Total Current Liabilities $5.3M
Long-Term Debt —
Total Liabilities $5.3M
Stockholders' Equity
Retained Earnings $-32.8M
Total Stockholders' Equity $61.6M
← Newer Page 2 of 2 Older →